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The organoselenium compounds have been reported for many biological properties, especially as potent
antioxidants. The compound bis(phenylimidazoselenazolyl) diselenide (BPIS) is a novel diaryl diselenide
derivative, which shows antinociceptive and anti-inﬂammatory properties in mice, but whose antioxi-
dant activity has not been studied. The present study aimed to investigate the antioxidant and toxicologi-
cal potential of BPIS in brain of rats in vitro, and the effect of BPIS against the oxidative damage induced
by sodium nitroprusside (SNP) in mouse brain. BPIS, at low molecular range, reduced lipid peroxidation
(LP) and protein carbonyl (PC) content in rat brain homogenates (IC50 values of 1.35 and 0.74 lM, respec-
tively). BPIS also presented dehydroascorbate reductase-like and glutathione-S-transferase-like, as well
as DPPH and NO-scavenging activities. Related to togicological assays, BPIS inhibited d-ALA-D and Na+,
K+-ATPase activities in rat brain homogenates and [3H]glutamate uptake in synaptosomes in vitro, but
these effects were observed at higher concentrations than it had antioxidant effect (IC50 values of
16.41, 26.44 and 3.29 lM, respectively). In vivo, brains of mice treated with SNP (0.335 lmol per site;
i.c.v.) showed an increase in LP and PC and a reduction in non protein thiol content, however, it was
not observed signiﬁcant alterations in antioxidant enzyme activities. BPIS (10 mg/kg; p.o.) protected
against these alterations caused by SNP. In conclusion, the results demonstrated the antioxidant action
of BPIS in in vitro assays. Furthermore, BPIS protected against oxidative damage caused by SNP in mouse
brain, strengthening the potential antioxidant effect of this compound.
 2015 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Reactive oxygen species (ROS), electrophilic molecules which
are physiologically produced can react with lipids, proteins and
nucleic acids, resulting in oxidative damage to these macro-
molecules, when produced in high concentrations [4]. ROS can also
react with nitric oxide (NO), forming the reactive nitrogen species
(RNS), which are equally deleterious [42]. Both species are gener-
ally detoxiﬁed by cellular enzymatic and non-enzymatic antioxi-
dant compounds, maintaining the natural redox state of the cell
[42].
However, in situations when there is an imbalance between the
production of ROS/RNS and the natural antioxidants; this event is
called oxidative stress, which can lead to cell damage. Studies have
reported the involvement of oxidative stress in the pathophysiology
of diseases and neurodegenerative processes like aging [4], inﬂam-
mation [46] and cancer [17].Sodium Nitroprusside (SNP; Fig. 1A) is considered a NO donor,
generally used as an inductor of apoptosis and oxidative stress
in vitro and in vivo [26,23]. SNP interacts with oxyhemoglobin in
the blood to produce methemoglobin while releasing cyanide
(CN) and NO spontaneously [24]. Then, SNP could induce reduc-
tion of enzyme mitochondrial activity as well as production of
ROS and RNS, triggering to oxidative stress and subsequently cellu-
lar damage [5,24].
The interest in the treatment of diseases related to oxidative
stress with antioxidants has increased in the last years [31].
Intending to prevent the oxidative stress-related damage, natural
and synthetic antioxidants are tested in in vitro and in vivo models
of toxicity [27,20].
In this context, a special attention can be given to the organose-
lenium compounds and their derivatives. This class of compounds
has been reported as potent antioxidants, and this property seems
to be related to their ability to mimick enzymes as glutathione
peroxidase (GPx), dehydroascorbate reductase (DHAR) and glu-
tathione-S-transferase (GST), as well as act as substrate for the
Fig. 1. Chemical structure of (A) SNP and (B) BPIS.
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slight modiﬁcations in molecular structures could partially or com-
pletely alter the effect of a drug, novel organoselenium compounds
have been synthesized. The compound bis(phenylimidazoselena-
zolyl) diselenide (BPIS; Fig. 1B) is a novel diaryl diselenide deriva-
tive, which has been already proven to have antinociceptive and
anti-inﬂammatory properties in mice [7] but its antioxidant activ-
ity has not been studied.
Whereasmany of the organoselenium compounds properties are
related to their antioxidant activity, the present study aimed to
investigate the antioxidant potential of BPIS in vitro. Toxicological
assays, such as the effect of BPIS on the activity of sulfhydryl
enzymes and glutamate uptake, which are end points related to
organoselenium compounds toxicity, were also performed. Based
on the in vitro data, we also evaluated the in vivo effect of BPIS on
the model of SNP-induced cerebral oxidative stress.2. Material and methods
2.1. Chemicals
BPIS was prepared and characterized according to Roehrs et al.
[40]. Analysis of the 1H NMR and 13C NMR spectra shed analytical
and spectroscopic data in full agreement with its assigned struc-
ture [40]. The chemical purity of BPIS (99.9%) was determined by
GC/MS. 2,20-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)
(ABTS) diammonium salt, d-aminolevulinic acid (d-ALA), ascorbic
acid, adenosine 50-triphosphate (ATP) disodium salt hydrate, 1-
chloro-2,4-dinitrobenzene (CNDB), 5,50-dithiobis-(2-nitrobenzoic
acid) (DTNB), 20,70-dichloroﬂuorescin diacetate (DCF-DA), 2,2-
diphenyl-1-picrylhydrazyl (DPPH), [3H]-L-glutamic acid, glu-
tathione (GSH), SNP, thiobarbituric acid (TBA) and vanadium (III)
chloride were purchased from the Sigma Chemical Co. (St Louis,
Missouri, USA). All other chemicals were of analytical grade and
obtained from standard commercial suppliers. BPIS was dissolved
in dimethylsulfoxide (DMSO) and canola oil for in vitro and
in vivo experiments, respectively.
2.2. Animal
Male adult albino Wistar rats (200–300 g) and male adult
C57BL/6 mice (25–35 g) from our own breeding colony were used
for in vitro and in vivo experiments, respectively. Animals were
kept on a separate animal room, in a 12 h light/dark cycle, at a
room temperature of 22 ± 2 C, with free access to food (Guabi,
RS, Brazil) and water. The animals were used according to the
guidelines of the Committee on Care and Use of Experimental
Animal Resources, Federal University of Santa Maria, Brazil
(#066/2014).
2.3. Tissue preparation
Animals were killed and the brain tissue was rapidly dissected,
weighed and placed on ice. Tissues were immediatelyhomogenized in cold 50 mM Tris–HCl, pH 7.4 (1/5, w/v). Protein
carbonyl content was assayed using the fresh brain homogenate
without centrifugation. For in vitro lipid peroxidation, d-aminole-
vulinate dehydratase (d-ALA-D) and Na+, K+-ATPase assays, the
homogenate was centrifuged at 2400g for 10 min to yield a pellet
that was discarded and a low-speed supernatant (S1), the latter
was used to determine the effect of different concentrations of
BPIS on the previously mentioned assays. Differently, for the
[3H]glutamate uptake assay, the rats were decapitated and the
whole brain was removed and used to prepare synaptosomes [45].
2.4. In vitro experiments
The in vitro experiments were carried out in order to investigate
the antioxidant and potential toxicological effect of BPIS.
2.4.1. Lipid peroxidation induced by Fe (II)/EDTA
Fe(II)/EDTA were used as classical inductors of lipid peroxida-
tion. An aliquot of 200 lL of S1 was added to the reaction mixture
containing: 30 lL of 500 lM EDTA solution (in water), 30 lL of
1.44 mM FeCl2 solution and 10 lL of BPIS at different concentra-
tions (ﬁnal concentrations of 0.1 to 5 lM) and water to complete
a ﬁnal volume of 300 lL. The FeCl2 solution was prepared in water,
maintained in a dark tube on the ice and immediately used.
Afterward the mixture was pre-incubated at 37 C for 1 h. The
reaction product was determined using 500 lL TBA (0.8%),
200 lL sodium dodecyl sulfate (SDS, 8.1%) and 500 lL acetic acid
(pH 3.4) with subsequent incubation at 95 C for 1 h. TBA reactive
species (TBARS) were spectrophotometrically determined at
532 nm as previously described [33], using malondialdehyde
(MDA, an end product of the peroxidation of lipids) as an external
standard. Results were expressed as nmol MDA/g tissue. Ascorbic
acid (ﬁnal concentration 1–1000 lM) was used as positive control.
2.4.2. Protein carbonyl determination
Carbonyl content was assayed by a method based on the reac-
tion of protein carbonyls with dinitrophenylhydrazine (DNPH)
forming dinitrophenylhydrazone [39]. Homogenate was diluted
with Tris–HCl buffer, pH 7.4 in a proportion of 1:8
(homogenate:Tris–HCl). Aliquots of 940 lL of homogenate dilu-
tions were incubated at 37 C for 2 h in the presence of 10 lL of
BPIS at different concentrations (ﬁnal concentrations of 0.1–
1 lM) and 50 lL of 20 mM SNP. SNP was used to stimulate the pro-
tein carbonyl production and was prepared in water, maintained in
a dark tube on the ice and immediately used. In two tubes, it was
added 200 lL of 10 mM DNPH in 2.0 M HCl. In the third tube, only
200 lL of 2.0 M HCl solution (blank) was added. All tubes were
incubated for 1 h at room temperature, in dark and shaken using
a vortex mixer every 15 min. After that, 0.5 mL of denaturizing buf-
fer (sodium phosphate buffer, pH 6.8, containing 3% SDS), 1.5 mL of
ethanol and 1.5 mL of hexane were added to all tubes. The tubes
were shaken with a vortex mixer for 40 s and centrifuged for
15 min at 2400g. The pellet obtained was separated, washed two
times with 1 mL of ethanol: ethyl acetate (1:1, volume/volume),
and dried at room temperature for 2 min. The pellet was immedi-
ately dissolved in 1 mL of denaturizing buffer solution with mixing.
Absorbance was measured at 370 nm. Results were expressed as
carbonyl content (nmol carbonyl content/mg protein). Trolox (ﬁnal
concentration 1–100 lM) was used as positive control.
2.4.3. Dehydroascorbate (DHA) reductase-like assay
The DHA reductase-like activity of BPIS was assayed as
described previously with minor modiﬁcations [50,49]. In brief,
10 lL of BPIS at different concentrations (ﬁnal concentrations of
0.1–25 lM) were incubated (2 min) with 955 lL of 100 mM
sodium phosphate buffer, pH 6.9, at 25 C in the presence or
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3 mM, diluted in water) in a ﬁnal volume of 1 mL. The mixture
was incubated at 25 C for 2 min. The DHA reductase assay was
initiated by adding 25 lL of 20 mM DHA to a ﬁnal volume of
1.0 mL. DHA solution was prepared on the day of experiments.
For this end, ascorbic acid was added to a solution containing
10 mM sodium phosphate dibasic and 0.5 mM EDTA to achieve a
ﬁnal concentration of 20 mM ascorbic acid. The pH of mixture
was adjusted to 5.5 with NaOH. After that, 10 lL of bromine to
each 2 mL of ascorbic acid solution pH 5.5 were added and mixed
at room temperature for 30 s. Afterward, the solution was bubbled
in argon for 10 min. The DHA solution obtained was stored pro-
tected from light in ice for up to 4 h. Ascorbic acid regeneration
from DHA was recorded at 265 nm. A blank without BPIS was
run, and the difference gave the BPIS DHA reductase activity in
nmol/min using the molar extinction coefﬁcient of ascorbic acid
of 14,700 cm1M1. Ebselen (ﬁnal concentration 1–25 lM) was
used as positive control.
2.4.4. Glutathione S-transferase (GST)-like assay
The reaction of GSH with CDNB is typically the preferred system
used to measure the catalysis imparted by naturally occurring GSTs
[14]. An aliquot of 10 lL of BPIS at different concentrations (ﬁnal
concentrations of 0.1–25 lM) was incubated with 20 lL of
50 mM GSH and 950 lL of 100 mM sodium phosphate buffer, pH
6.9 at 25 C for 3 min. The reaction was initiated by adding 20 lL
of 25 mM CDNB to achieve a ﬁnal volume of 1.0 mL and recorded
for 3 min at 340 nm. This assay was also performed without GSH
in order to discard possible direct reaction of CDNB with BPIS.
CDNB was used as substrate. A blank without BPIS was included
and the difference was expressed as Dabs (delta absorbance)/
min. Ebselen (ﬁnal concentration 1–25 lM) was used as positive
control.
2.4.5. Scavenging activity of ABTS radical
The determination of the ABTS radical scavenging activity was
performed according to the method previously described with
some modiﬁcations [38]. Initially, the ABTS radical was generated
by reacting 7 mM ABTS solution in water with 140 mM potassium
persulfate in the dark for 12–16 h. In the day of the assay, the pre-
formed ABTS radical solution was diluted in potassium phosphate
buffer in a proportion of 1:88 (1 mL ABTS radical + 87 mL 10 mM
potassium phosphate buffer, pH 7.0). Brieﬂy, 1 mL of ABTS radical
solution was added to tubes containing 10 lL of BPIS at different
concentrations (ﬁnal concentrations of 0.1–100 lM). The mixture
was incubated at 25 C for 30 min in dark. The decrease in absor-
bance was measured at 734 nm. Ascorbic acid (1–25 lM) was used
as a positive control. Results were expressed as percentage of the
control. Ascorbic acid (ﬁnal concentration 0.1–100 lM) was used
as positive control.
2.4.6. Scavenging activity of DPPH radical
Radical-scavenging activity was determined by the reaction of
the stable DPPH radical with the compound in accordance with
the method previously described [8]. An aliquot of 10 lL of BPIS
at different concentrations (ﬁnal concentrations of 0.1–100 lM)
was mixed with 1 mL of methanolic solution containing DPPH radi-
cal, resulting in a ﬁnal concentration of 85 lM DPPH. The mixture
was left to stand for 30 min at room temperature in the dark and
the absorbance was measured at 517 nm. Results are expressed
as percentage of the control. Ascorbic acid (ﬁnal concentration
0.1–100 lM) was used as positive control.
2.4.7. Scavenging activity of NO and related species (NOx)
The procedure is based on the principle that SNP in aqueous
solution at physiological pH spontaneously generates NO. For theexperiment, SNP (10 mM) was mixed with different concentrations
of BPIS (ﬁnal concentrations of 1–100 lM) and incubated at room
temperature for 150 min. The same reaction mixture, without the
compounds but with an equivalent amount of water, served as
the control. After the incubation period, 0.5 mL of Griess reagent
(1% sulfanilamide, 2% phosphoric acid and 0.1% N-(1-naphthyl)
ethylenediamine dihydrochloride) was added. The NO generated
interacts with oxygen to produce nitrite ions that can be estimated
using this reagent. Then, NO scavengers could reduce the produc-
tion of nitrite ions. The absorbance of the chromophore formed
was read at 540 nm [28]. The oxime butane-2,3-dionethiosemicar-
bazone (OXIME; ﬁnal concentration 25 lM) was used as positive
control [37].
2.4.8. d-ALA-D activity
d-ALA-D activity was assayed according to the method described
by Sassa [41], with some modiﬁcations. S1 (200 lL) was pre-incu-
bated for 10 min at 37 C in the presence of BPIS at different concen-
trations (ﬁnal concentrations of 1–25 lM) or DMSO in the control
tube. The enzymatic reaction was initiated by adding the substrate
(d-ALA) to a ﬁnal concentration of 2.2 mM in a medium containing
45 mM phosphate buffer, pH 6.8 and incubated for 3 h at 37 C.
The incubation was stopped by adding 10% trichloroacetic acid solu-
tion (TCA) with 10 mM HgCl2. The reaction product (porphobilino-
gen) was measured at 555 nm using modiﬁed Ehrlich’s reagent.
The values are expressed as nmol PBG/mg protein/h.
2.4.9. Na+, K+-ATPase activity
The reaction mixture for Na+, K+-ATPase activity assay con-
tained 3 mM MgCl2, 125 mM NaCl, 20 mM KCl, and 50 mM Tris/
HCl, pH 7.4, in a ﬁnal volume of 500 lL. S1 (50 lL) was pre-incu-
bated at 37 C for 10 min in the presence of BPIS (ﬁnal concentra-
tions of 1–100 lM) or DMSO. The reaction was initiated by the
addition of ATP to a ﬁnal concentration of 3.0 mM and incubated
at 37 C for 30 min. For obtaining the ouabain-sensitive activity,
other samples were carried out under the same conditions with
the addition of 0.1 mM ouabain. Na+, K+-ATPase activity was calcu-
lated by the difference between the two assays. Released inorganic
phosphate (Pi) was measured by the method of Fiske and
Subbarow [13]. The values are expressed as nmol Pi/mg protein/h.
2.4.10. [3H]glutamate uptake by synaptosomes
[3H]glutamate uptake was assayed according to [45]. The
synaptosomal preparation was washed twice by suspending in
three volumes of 0.3 M sucrose, in 15 mM Tris/acetate buffer (pH
7.4), and centrifuging at 35,000g for 15 min. The ﬁnal pellet was
suspended in 0.3 M sucrose, 15 mM Tris/acetate buffer (pH 7.4),
and incubated in Tris/HCl buffer (composition in mM Tris/HCl 27,
NaCl 133, KCl 2.4, MgSO4 1.2, KH2PO4 1.2, Glucose 12, CaCl2 1.0)
pH 7.4 (adjusted with HCl), in the presence of BPIS (ﬁnal concen-
trations of 1.75–5 lM) or DMSO for 10 min at 37 C. The
[3H]glutamate uptake was initiated by adding to the medium
[3H]glutamate (ﬁnal concentration 100 mM) for 1 min at 37 C.
The reaction was stopped by centrifugation (16,000g, 1 min,
4 C), and the pellets were washed three times in Tris/HCl buffer
by centrifugation at 16,000g for 1 min (at 4 C). Radioactivity pre-
sent in pellet was measured in a scintillation counter. Speciﬁc
[3H]glutamate uptake was calculated as the difference between
the uptake obtained in the incubation medium described above,
and the uptake obtained with a similar incubation medium in
which NaCl was replaced by choline chloride.
2.5. In vivo experiments
Considering that the in vitro experiments pointed out the
antioxidant properties of BPIS, the compound was used to
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the brain of C57BL/6 mice.
2.5.1. Protocol of Exposure
Mice were divided into 4 groups of 7–9 animals each. Animals
belonging to groups I and III received oral application of canola
oil (10 mL/kg of body weight). Mice of groups II and IV received
oral administration of BPIS (10 mg/kg). Thirty minutes after the
treatment, mice of groups III and IV received SNP (0.335 lmol
per site/2 lL) intracerebroventricular (i.c.v.). Groups I and II
received saline solution (i.c.v.). The dosage of SNP was based on
our previous study [36] and the BPIS dose was selected based on
our previous study that demonstrated the antinociceptive action
of BPIS through a series of acute models [7]. I.c.v. injections were
given as described previously [22], with the bregma ﬁssure as a
reference point.
2.5.2. Tissue preparation
One hour after SNP or saline administration all mice were kiled
and the brains of animals were removed and homogenized as
described in Section 2.3. The low-speed supernatants (S1) were
separated and used for in vivo assays. For protein carbonyl content,
it was used the homogenate without centrifugation. In addition for
NOx levels, the brains were homogenized with ZnSO4 (200 mM)
and acetonitrile (96%), centrifuged at 16,000g at 4 C for 30 min,
and the supernatant was collected.
2.5.3. Lipid peroxidation
Lipid peroxidation was carried out with an aliquot of S1 (200 lL)
as described in Section 2.4.1, excepting for the absence of the
preincubation step.
2.5.4. Reactive species (RS) determination
RS levels were determined by a spectroﬂuorimetric method,
using DCHF-DA assay [25]. S1 (10 lL) was incubated with 10 lL
of DCHF-DA (1 mM). The oxidation of DCHF-DA to ﬂuorescent
dichloroﬂuorescein (DCF) is measured for the detection of intra-
cellular RS. The DCF ﬂuorescence intensity emission was recorded
at 520 nm (with 480 nm excitation) 30 min after the addition of
DCHF-DA to the medium. RS levels were expressed as arbitrary
units (AU) of ﬂuorescence/g tissue.
2.5.5. Non-protein thiol (NPSH) content
NPSH levels were determined by the method previously
described [10]. To determine NPSH, S1 was mixed (1:1) with 10%
trichloroacetic acid. After the centrifugation, the protein pellet
was discarded and free –SH groups were determined in the clear
supernatant. An aliquot of supernatant was added in 1 M potas-
sium phosphate buffer pH 7.4 and 10 mM DTNB. The color reaction
was measured at 412 nm. NPSH levels were expressed as optic
density (DO)/g tissue.
2.5.6. Protein carbonyl determination
Protein carbonyl content was carried out with an aliquot of
940 lL of a homogenate diluted with Tris–HCl buffer, pH 7.4 in a
proportion of 1:8, as described above Section 2.4.2, excepting for
the absence of the preincubation step.
2.5.7. NOx levels
The brains were dissected on an inverted ice-cold Petri dish and
homogenized with ZnSO4 (200 mM) and acetonitrile (96%), cen-
trifuged at 16,000g at 4 C for 30 min, and the supernatant was col-
lected for assay of the nitrite plus nitrate content [28]. NOx content
was estimated in a medium containing 900 mL of the previously
described Griess Reagent. After incubating at 37 C for 60 min,nitrite levels were determined spectrophotometrically at 540 nm,
based on NOx/g tissue.
2.5.8. Catalase (CAT) activity
Enzymatic reaction was initiated by adding an aliquot of 20 lL
of the S1 and the substrate (H2O2) to a concentration of 0.3 mM in a
medium containing 50 mM phosphate buffer, pH 7.5. The enzy-
matic activity was measured at 240 nm and expressed as Unit
(U)/mg protein (1 U decomposes 1 lmol of H2O2 per minute at
pH 7 at 25 C) [1].
2.5.9. Superoxide dismutase (SOD) activity
S1 was diluted 1:10 (v/v) for determination of SOD activity in the
test day. Aliquots of supernatant were added in a Na2CO3 buffer
50 mM pH 10.3. Enzymatic reaction was started by adding of epi-
nephrine. The color reaction was spectrophotometrically measured
at 480 nm.Oneunit of enzymewasdeﬁnedas the amountof enzyme
required to inhibit the rate of epinephrine autoxidation by 50% at
26 C [29]. The enzymatic activity was expressed as U/mg protein.
2.5.10. Glutathione-S-trasferase (GST) activity
GST activity was assayed spectrophotometrically at 340 nm by
the method of Habig et al. [14]. The reaction mixture contained
an aliquot of S1, 0.1 M potassium phosphate buffer pH 7.4,
100 mM GSH and 100 mM CDNB, which was used as substrate.
The enzymatic activity was expressed as nmol CDNB conjugate/
min/mg ptn.
2.5.11. Glutathione reductase (GR) activity
GR activity in S1 was determined as described by Calberg and
Mannervik [6]. In this assay, GSSG is reduced by GR at the expense
of NADPH consumption, which was followed at 340 nm. GR activ-
ity is proportional to NADPH decay. The enzymatic activity was
expressed as nmol NADPH/min/mg protein.
2.5.12. Glutathione peroxidase (GPx) activity
GPx activity in S1 was assayed spectrophotometrically by the
method of Wendel [51], through the GSH/NADPH/glutathione
reductase system, by the dismutation of H2O2 at 340 nm. S1 was
added in GSH/NADPH/glutathione reductase system and the enzy-
matic reaction was initiated by adding H2O2. In this assay, the
enzyme activity was indirectly measured by means of NADPH
decay. H2O2 is reduced and generates GSSG from GSH. GSSG is
regenerated back to GSH by glutathione reductase present in the
assay media at the expenses of NADPH. The enzymatic activity
was expressed as nmol NADPH/min/mg protein.
2.6. Protein quantiﬁcation
Protein concentration was measured by the method of Bradford
[3], using bovine serum albumin (1 mg/mL) as the standard.
2.7. Statistical analysis
The results are presented as mean ± SEM. For in vitro experi-
ments, the data were performed using one-way analysis of variance
followedby theNewman–Keul’smultiple range testwhenappropri-
ate. The IC50 values were calculated considering responses between
20 and 80% and reported as geometric means accompanied by their
95% conﬁdence limits, using the program GraphPad InSTAT.
Maximal inhibition (IMAX) values were calculated at the most effec-
tive dose used. For in vivo experiments, data were analyzed using
two-way analysis of variance (ANOVA) followed by the Newman–
Keul’s multiple range test when appropriate. p values less than
0.05 (p < 0.05) were considered as indicative of signiﬁcance.
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3.1. In vitro experiments
3.1.1. Effect of BPIS on Fe (II)/EDTA-induced TBARS in rat brain
homogenate
BPIS signiﬁcantly reduced the lipid peroxidation induced in rat
brain homogenate at concentrations equal or greater than 1 lM
[F(7,16) = 36.03; p < 0.001] (Fig. 2A). The IC50 value was 1.35 (1.29–
1.42) lM and IMAX 89 ± 1%. The positive control ascorbic acid was
only effective in the concentration of 1000 lM with IMAX 38 ± 6%
(data not shown).Fig. 2. Effect of BPIS on (A) lipid peroxidation induced by Fe(II)/EDTA and (B) protein
Reductase-like and (D) GST-like activities of BPIS; (E) ABTS, DPPH and NOx-scavenging ac
duplicate, in different days, using different animals. (*) denotes p < 0.05 as compared to th
compared to the induced; (##) denotes p < 0.01 as compared to the induced; (###) den3.1.2. Effect of BPIS on protein carbonyl production induced by SNP in
rat brain homogenate
As seen in Fig. 2B, BPIS decreased the protein carbonyl levels
induced by SNP in rat brain homogenate at concentrations equal
or greater than 0.5 lM [F(6,14) = 39.58; p < 0.001]. The IC50 value
was 0.74 (0.70–0.77) lM and IMAX 65 ± 5%. The positive control tro-
lox was effective at concentrations equal or greater than 50 lM
with IMAX 32 ± 2% (data not shown).
3.1.3. DHA-Reductase-like activity of BPIS
BPIS, at concentration equal or greater than 5 lM demonstrated
DHA-Reductase-like activity, being effective to reduce DHA tocarbonyl production induced by SNP in rat brain homogenates in vitro; (C) DHA-
tivities of BPIS. Data are reported as mean ± SEM for 3–4 experiments performed in
e control; (***) denotes p < 0.001 as compared to the control; (#) denotes p < 0.05 as
otes p < 0.001 as compared to the induced (one way ANOVA/Newman–Keuls).
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centration of BPIS, but similar to the different concentrations
of GSH (Fig. 2C): in the presence of 1 mM of GSH [F(6,14) = 86.45;
p < 0.001]; 2 mM of GSH [F(6,14) = 29.24; p < 0.001] and 3 mM
of GSH [F(6,14) = 73.18; p < 0.001]. The assay was also performed
without GSH, and no ascorbic acid formation was observed, dis-
carding any direct reaction of BPIS directly to DHA (data not
shown).
The positive control ebselen did not show DHA-Reductase-like
activity in the presence of 1 mM of GSH. In the presence of 2 mM
of GSH, ebselen showed DHA-Reductase-like activity at concentra-
tion equal or greater than 10 lM. At last, in the presence of 3 mM
of GSH, ebselen showed DHA-Reductase-like activity at concentra-
tion equal or greater than 5 lM (data not shown).3.1.4. GST-like activity of BPIS
The data show that BPIS had GST-like activity in concentrations
equal or greater than 5 lM [F(5,12) = 103.0; p < 0.01] (Fig. 2D). The
assay was also performed without GSH, and no product formation
was observed, discarding any direct reaction of BPIS directly to
CDNB (data not shown). The positive control ebselen only showed
a signiﬁcant GST-like activity at the concentration of 25 lM (data
not shown).3.1.5. ABTS and DPPH radical-scavenging activity
As seen in Fig. 2E, BPIS did not show ABTS radical scavenging
activity at assayed concentrations [F(6,14) = 1.952; p = 0.1418]. By
contrast, BPIS showed DPPH radical scavenging activity at concen-
trations equal or greater than 50 lM [F(6,14) = 14.79; p < 0.001]
(Fig. 2F). For the DPPH assay, the IC50 value was not calculated con-
sidering that the IMAX was 36 ± 7%.
The positive control ascorbic acid showed both ABTS and DPPH
radical-scavenging activity at concentrations equal or greater than
5 lM (data not shown). For the ABTS assay the IC50 value was
8.63 lM and IMAX was 96 ± 1% and for DPPH assay the IC50 value
was 9.01 lM and IMAX was 93 ± 2%.Fig. 3. Effect of BPIS on (A) d-ALA-D, (B) Na+, K+-ATPase activities in rat brain
homogenates and (C) [3H]glutamate uptake by synaptosomes in vitro. Data are
reported as mean ± SEM for 3–5 experiments performed in duplicate, in different
days, using different animals. (*) denotes p < 0.05 as compared to the control; (**)
denotes p < 0.01 as compared to the control; (***) denotes p < 0.001 as compared to
the control (one way ANOVA/Newman–Keuls).3.1.6. NOx-scavenging activity
BPIS diminuished the NO and related species formation induced
by SNP at concentrations equal or greater than 10 lM
[F(7,16) = 32.63;p < 0.001] (Fig. 2G). The IC50 valuewas not calculated
considering that the IMAX was 45 ± 4%. OXIMEwas evaluated only in
the concentration of 25 lM, it presented inhibition of 43 ± 4%.3.1.7. Effect of BPIS on d-ALA-D Activity in rat brain homogenate
BPIS signiﬁcantly reduced the d-ALA-D activity from rat brain
homogenate at concentrations equal or greater than 10 lM
[F(4,10) = 15.82; p < 0.001] (Fig. 3A). The IC50 value was 16.41 lM
(15.25–17.65) and IMAX was 74 ± 14%.3.1.8. Effect of BPIS on Na+, K+-ATPase activity in rat brain homogenate
As seen in Fig. 3B, BPIS showed a dual effect on the Na+, K+-
ATPase activity in rat brain homogenates, signiﬁcantly acting as
an enzyme inductor at low concentrations (i.e. 1–10 lM) and as
an inhibitor at high concentrations (i.e. equal or greater than
50 lM) [F(6,14) = 37.96; p < 0.001]. The IC50 value was 26.44
(25.55–27.36) lM and IMAX value was 86 ± 10%.3.1.9. Effect of BPIS on [3H]glutamate uptake by synaptosomes
BPIS signiﬁcantly inhibited [3H]glutamate uptake by synapto-
somes at concentrations equal or greater than 3.75 lM
[F(4,10) = 10.52; p < 0.01] (Fig. 3C). The IC50 value was 3.294 lM
and IMAX was 74 ± 10%.3.2. In vivo experiments
3.2.1. Lipid peroxidation
Two-way ANOVA of TBARS determination yielded a signiﬁcant
SNP  BPIS interaction [F(1,26) = 5.956; p < 0.05]. Post-hoc compar-
isons demonstrated that SNP signiﬁcantly induced lipid peroxida-
tion in brains of mice and BPIS protected against the increase in
these levels (Fig. 4A).
3.2.2. RS levels
According to two-way ANOVA, RS levels were not modiﬁed in
rats in none of the experimental groups [F(1,26) = 0.011; p = 0.973]
(Fig. 4B).
3.2.3. NPSH levels
Regarding the NPSH levels, the two-way ANOVA showed a sig-
niﬁcant interaction between SNP and BPIS [F(1,26) = 4.291; p < 0.05].
The BPIS pretreatment was effective in preventing the decrease in
NPSH levels caused by SNP i.c.v. injection in brains of mice
(Fig. 4C).
Fig. 4. Effect of BPIS (10 mg/kg) on (A) lipid peroxidation, (B) RS, (C) NPSH, (D) protein carbonyl and (E) NOx levels in brains of mice treated with SNP. Data are reported as
mean ± SEM of 7–9 animals per group. (*) denotes p < 0.05 as compared to the control group; (***) denotes p < 0.001 as compared to the control group; (#) denotes p < 0.05 as
compared to the SNP group; (##) denotes p < 0.01 as compared to the SNP group (two-way ANOVA/Newman–Keuls).
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In relation to carbonyl content, the two-way analysis revealed
that there a main effect of SNP i.c.v. injection [F(1,26) = 10.579;
p < 0.05]; however, there was no interaction between SNP and
BPIS treatments [F(1,26) = 0.018; p = 0.894] (Fig. 4D).3.2.5. NOx levels
As seen in Fig. 4E, two-way ANOVA indicated that the
administration of SNP and/or BPIS did not change NOx levels in
the brain of mice [F(1,26) = 0.049; p = 0.827].3.2.6. Antioxidant enzyme activities
Two-way analysis demonstrated that there was no signiﬁcant
interaction between SNP and BPIS treatments for CAT
[F(1,26) = 0.068; p = 0.796] (Fig. 5A), SOD [F(1,26) = 0.150; p = 0.702](Fig. 5B), GR [F(1,26) = 2.930; p = 0.099] (Fig. 5C) and GST activities
[F(1,26) = 2.464; p = 0.129] (Fig. 5D).
Regarding GPx activity, two-way ANOVA revealed a signifcant
main effect of BPIS treatment [F(1,26) = 5.106; p < 0.05] (Fig. 5E).
Although there was no signiﬁcant interaction between SNP and
BPIS treatments [F(1,26) = 3.53; p = 0.071], GPx data from animals
that received both BPIS and SNP was different from all the other
groups.
4. Discussion
The results of the present study demonstrate that the com-
pound BPIS had an in vitro and in vivo antioxidant activity. In vitro,
BPIS protected against lipid peroxidation induced by Fe (II)/EDTA
and protein carbonyl formation induced by SNP in rat brain homo-
genate. The mechanism of action by which BPIS shows antioxidant
Fig. 5. Effect of BPIS (10 mg/kg) on (A) CAT, (B) SOD, (C) GST, (D) GR and (E) GPx activity in brains of mice treated with SNP. Data are reported as mean ± SD of seven animals
per group. Data are reported as mean ± SEM of 7–9 animals per group. (@) denotes p < 0.05 as compared to all the other groups (two-way ANOVA/Newman–Keuls).
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as well as DPPH and NO-scavenging activity. It was also demon-
strated, that BPIS can inhibit enzymes such as d-ALA-d and Na+,
K+-ATPase and the glutamate uptake, which could represent a tox-
icological potential, however, these effects were demonstrated to
occur at higher concentrations than those of it showed antioxidant
potential. In in vivo experiments, BPIS protected against alterations
in parameters of oxidative stress induced by i.c.v. SNP administra-
tion, strengthening the BPIS potential as an antioxidant compound.
It is known that basal levels of ROS and RNS are physiologically
produced by several mechanisms, including partial reduction of O2
via mitochondrial electron transport chain, the oxidative deam-
ination of biogenic amines and as part of the immune response
by polymorphonuclear cells [4,11]. ROS and RNS are generally
detoxiﬁed by enzymatic and non-enzymatic antioxidant defenses,
maintaining the natural redox status of the cells [16]. However,
when there is an imbalance between the production of RS andthe natural antioxidant defenses, this situation is considered oxida-
tive stress. Diverse molecules can be oxidized due to an augment in
RS levels, among these macromolecules, we can mention protein,
lipids and nucleic acids, generating cellular damage [34].
Lipid peroxidation and protein carbonylation can be observed
in situations like aging, cancer and neurodegeneration [17,4,46].
The brain is extremely susceptible to oxidative stress, especially
because many areas of this organ are rich in non-haem iron, which
is catalytically involved in the generation of free radicals; as well as
the brain contains high degree of polyunsaturated fatty acids, sub-
strates particularly vulnerable to oxidation [15]. For this reason, we
investigated the in vitro antioxidant effect of BPIS in brain homoge-
nates, and the results demonstrated that BPIS acts as an antioxi-
dant at very low concentrations: The results demonstrated IC50
values of 1.35 lM in the lipid peroxidation induced by Fe(II)/
EDTA and 0.74 lM in the protein carbonyl production induced by
SNP. Studies have demonstrated organoselenium compounds,
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against models of oxidative stress [27,36,2].
However, BPIS showed lower IC50 values when compared to
other diselenides: for example, Prigol et al. [36] demonstrated that
among many disubstituted diaryl diselenides tested, p-chloro-
diphenyl diselenide (p-ClPhSe)2 showed the best antioxidant pro-
ﬁle (IC50 1.90 lM for SNP-induced lipid peroxidation, 2.7 lM for
malonate-induced lipid peroxidation and 85 lM for SNP-induced
protein carbonyl formation). Dithienyl diselenide (ThSe)2, another
parental compound, presented IC50 values of 15.33 lM for FE(II)/
EDTA-induced lipid peroxidation and 11.89 lM for SNP-induced
protein carbonyl formation.
Although the precise mechanism by which BPIS elicits antioxi-
dant activity is still not completely understood, a large part of its
action is the mimetic activity of the physiological enzymes DHA-
Reductase and GST. DHA-Reductase is the enzyme responsible for
the recycling of dehydroascorbate into ascorbic acid, one of the
most important physiological antioxidants and GST is a detoxifying
enzyme for xenobiotics, lipid peroxidation end products and other
oxidative stress-related molecules [50,43]. BPIS acts similar to
these enzymes, using GSH as a reducing agent in order to prevent
oxidative stress, then contributing to ascorbic acid recycling and
thiol-dependent xenobiotic detoxiﬁcation.
In addition, BPIS showed scavenging activity against free radi-
cals, represented by the ability to scavenge DPPH, as well as NO
and related compounds. ABTS and DPPH radical-scavenging activ-
ity assays are widely used as antioxidant activity screening, differ-
ences in the scavenging activity can be due to DPPH reactions
involve H-atom transfer and reactions with ABTS radicals involve
electron-transfer processes [30]. BPIS also demonstrated NOx scav-
enging activity, it is known that NO can undergo reactions with O2,
superoxide ion and reducing agents to produce RNS, such as
nitroxyl (HNO), the oxides NO2/N2O4, and N2O3, peroxynitrite,
and S-nitrosothiols (RSNO), molecules that contribute to nitrosa-
tive and oxidative stress [19]. We have to mention that the concen-
trations in which BPIS showed scavenger activities were higher
than those in which BPIS elicited antioxidant activity, but these
could be contributing to the sum of antioxidant properties of this
compound.
The inhibition of sulfhydryl enzymes, such as d-ALA-d and Na+,
K+-ATPase activities, and the blockade of glutamate uptake can
represent important points to be investigate related to the toxicity
of organoselenium compounds. The interaction with these
enzymes or transporter is associated with the fact that most of
organoselenium compounds are highly prone to attack thiol groups
present in these proteins [32]. d-ALA-D is an important enzyme
related to haem biosynthesis, Na+, K+-ATPase is responsible for
the active transport of sodium and potassium ions in the central
nervous system and the glutamate uptake, carried out by excita-
tory amino-acid transporters, regulates concentrations of gluta-
mate in the extracellular space [41,48,47]. The inhibition of these
pathways generally leads to excitotoxicity, a situation reported in
toxicity caused by high concentrations of organoselenium com-
pounds [31]. However, we have to highlight that these parameters
were mainly affected at higher concentrations than BPIS showed
antioxidant effect. Other interesting fact is that in low concentra-
tions, BPIS even stimulated the Na+, K+-ATPase activity; con-
sidering that oxidative regulation of this enzyme has important
implications, reducing agents could increase the Na+, K+-ATPase
activity or reverse the physiological inhibition caused by normal
oxidative status [12].
Based on the in vitro results, we expanded the study in order to
investigate the effect of an oral administration of BPIS on the
model of oxidative damage induced by i.c.v. injection of SNP in
mice. It was demonstrated that BPIS prevented against SNP-medi-
ated alterations in oxidative stress parameters in brains of mice.BPIS avoided the increase in lipid peroxidation levels and the
decrease in NPSH levels induced by the injection of SNP. SNP treat-
ment did not affect all of the analyzed parameters, but the oxida-
tion of protein, lipids and endogenous thiols is something to be
highlighted, whereas that these are important parameters of
oxidative stress [35].
Regarding that there is no signiﬁcant alteration in the levels of
RS or NOx in the animals treated with SNP, it could be reacting
more directly to lipids, thiols and proteins. We could not discard
that other species related to SNP and NO metabolism could be ele-
vated, whereas that the griess reagent mainly reacts with NO2 and
NO3. The greater prevalence and reactivity of thiols over other bio-
logical nucleophiles could explain the propensity for S-nitrosothiol
formation, what could explain the decrease in NPSH in the groups
that received only SNP. Thiols in the presence of electron acceptors
(redox-activated thiols) react with the nitrosonium moiety of NO
to form S-nitrosothiol which may represent a storage pool for NO
[19]. As already mentioned, SNP release cyanide and iron from its
structure, what induce reduction of enzyme mitochondrial activity
as well as production of ROS and RNS, triggering to oxidative stress
and damage, represented by the oxidation of macromolecules
[21,24]. We cannot afﬁrm, regarding that we do not know the con-
centrations of BPIS in the brain tissue, when administered orally,
but we can suppose that it could be acting detoxifying the SNP-in-
duced damage by mechanisms similar to observed in vitro, such as
GST- and DHA-Reductase-like, as wells as free radicals-scavenging
activities, especially to NO-related molecules.
SNP did not affect the activity of the evaluated antioxidant
enzymes (CAT, SOD, GR, GST and GPx), an important point to be
investigated, but that seems not to be related to the toxic effects
of SNP. Despite this, when the animals received both BPIS and
SNP, the GPx activity was increased. It is known that some organo-
selenium compounds could stimulate the expression of GPx, and
some organoselenium (e.g. selenocystein) can even be incorpo-
rated in selenoproteins as GPx [32,18]. However, the time follow-
ing exposure to SNP and/or BPIS and tissue extraction is
insufﬁcient for induction of the enzyme expression, and it seems
to merely reﬂects enzyme activation, this could also explain why
some enzyme activities were not affected by the treatments. GPx
is an antioxidant selenoenzyme that reduces variable hydroperox-
ides at the expense of glutathione and/or other reducing equiva-
lents [18]. One interesting point is that both situations were
necessary to increase GPx activity, just BPIS administration does
not increase its activity, but also in association with a situation
of oxidative damage.
Some of the limitations of this study include the dose of SNP
which does not generate much harm, even if the results related
to oxidative damage are similar to those observed in other studies
[36,44]. In addition, the in vitro data cannot be extrapolated to the
in vivo because the blood or brain concentrations of BPIS were not
determined after oral administration of this compound to mice and
in view of the fact that these experiments were carried out with
species differentes. Despite these limitations, the present study
provides valuable information for the in vitro and in vivo antioxi-
dant potential of BPIS.5. Conclusions
In conclusion, the results demonstrated the in vitro antioxidant
action of BPIS on rat brain homogenates, at low concentrations, and
this could be explained for its ability to mimic physiological
antioxidant enzymes, as well as scavenge free radicals. BPIS admi-
nistered to mice protected against alterations in parameters of
oxidative stress caused by SNP in mouse brain, strengthening the
potential antioxidant effect of this compound. Although the results
P.M. Chagas et al. / Chemico-Biological Interactions 233 (2015) 14–24 23showed here indicate that BPIS might be a good candidate for
future drug development in the prevention or treatment of dis-
eases related to oxidative stress, more results would be required
for better understanding the complete mechanism by which this
compound acts and its physiological effects.Source of funding
UFSM, CAPES, CNPq, FAPERGS.Conﬂict of Interest
The authors declare that there are no conﬂicts of interest.Transparency Document
The Transparency document associated with this article can be
found in the online version.References
[1] H. Aebi, Catalase in vitro, Methods Enzymol. 105 (1984) 121–126.
[2] C.F. Bortolatto, P.M. Chagas, E.A. Wilhelm, G. Zeni, C.W. Nogueira, 2,20-
Dithienyl diselenide, an organoselenium compound, elicits antioxidant action
and inhibits monoamine oxidase activity in vitro, J. Enzyme Inhib. Med. Chem.
28 (2013) 677–684.
[3] M.M. Bradford, A rapid and sensitive method for the quantitation of microgram
quantities of protein utilizing the principle of protein-dye binding, Anal.
Biochem. 72 (1976) 248–254.
[4] E. Cadenas, K.J. Davies, Mitochondrial free radical generation, oxidative stress,
and aging, Free Radic. Biol. Med. 29 (2000) 222–230.
[5] S. Cardaci, G. Filomeni, G. Rotilio, M.R. Ciriolo, Reactive oxygen species mediate
p53 activation and apoptosis induced by sodium nitroprusside in SH-SY5Y
cells, Mol. Pharmacol. 74 (2008) 1234–1245.
[6] I. Carlberg, B. Mannervik, Glutathione reductase, Methods Enzymol. 113 (1985)
484–490.
[7] P.M. Chagas, C.F. Bortolatto, E.A. Wilhelm, J.A. Roehrs, C.W. Nogueira,
Bis(phenylimidazoselenazolyl) diselenide: a compound with antinociceptive
properties in mice, Behav. Pharmacol. 24 (2013) 37–44.
[8] C.W. Choi, S.C. Kim, S.S. Hwang, B.K. Choi, H.J. Ahn, M.Y. Lee, S.H. Park, S.K. Kim,
Antioxidant activity and free radical scavenging capacity between Korean
medicinal plants and ﬂavonoids by assay-guided comparison, Plant Sci. 163
(2002) 1161–1168.
[9] A.S. de Freitas, V.R. Funck, S. Rotta Mdos, D. Bohrer, V. Morschbacher, R.L.
Puntel, C.W. Nogueira, M. Farina, M. Aschner, J.B. Rocha, Diphenyl diselenide, a
simple organoselenium compound, decreases methylmercury-induced
cerebral, hepatic and renal oxidative stress and mercury deposition in adult
mice, Brain Res. Bull. 79 (2009) 77–84.
[10] G.L. Ellman, Tissue sulfhydryl groups, Arch. Biochem. Biophys. 82 (1959) 70–
77.
[11] L. Fialkow, Y. Wang, G.P. Downey, Reactive oxygen and nitrogen species as
signaling molecules regulating neutrophil function, Free Radic. Biol Med 42
(2007) 153–164.
[12] G.A. Figtree, C.C. Liu, S. Bibert, E.J. Hamilton, A. Garcia, C.N. White, K.K. Chia, F.
Cornelius, K. Geering, H.H. Rasmussen, Reversible oxidative modiﬁcation: a
key mechanism of Na+-K+ pump regulation, Circ. Res. 105 (2009) 185–193.
[13] C.H. Fiske, Y. Subbarow, The colorimetric determination of phosphorus, J. Biol.
Chem. 66 (1925) 375–400.
[14] W.H. Habig, M.J. Pabst, W.B. Jakoby, Glutathione S-transferases. The ﬁrst
enzymatic step in mercapturic acid formation, J. Biol. Chem. 249 (1974) 7130–
7139.
[15] B. Halliwell, Reactive oxygen species and the central nervous system, J.
Neurochem. 59 (1992) 1609–1623.
[16] B. Halliwell, J.M. Gutteridge, Role of free radicals and catalytic metal ions in
human disease: an overview, Methods Enzymol. 186 (1990) 1–85.
[17] W. Huber, B. Kraupp-Grasl, H. Esterbauer, R. Schulte-Hermann, Role of
oxidative stress in age dependent hepatocarcinogenesis by the peroxisome
proliferator nafenopin in the rat, Cancer Res. 51 (1991) 1789–1792.
[18] E. Ibanez, M. Stoedter, P.J. Hofmann, D. Plano, A. Calvo, P.A. Nguewa, J.A. Palop,
C. Sanmartin, L. Schomburg, Structure- and cell-speciﬁc effects of
imidoselenocarbamates on selenoprotein expression and activity in liver
cells in culture, Metallomics 4 (2012) 1297–1307.
[19] M. Kelm, Nitric oxide metabolism and breakdown, Biochim. Biophys. Acta
1411 (1999) 273–289.[20] M. Kerman, B. Cirak, M.F. Ozguner, A. Dagtekin, R. Sutcu, I. Altuntas, N. Delibas,
Does melatonin protect or treat brain damage from traumatic oxidative
stress?, Exp Brain Res. 163 (2005) 406–410.
[21] H.J. Kim, I. Tsoy, M.K. Park, Y.S. Lee, J.H. Lee, H.G. Seo, K.C. Chang, Iron released
by sodium nitroprusside contributes to heme oxygenase-1 induction via the
cAMP-protein kinase A-mitogen-activated protein kinase pathway in RAW
264.7 cells, Mol. Pharmacol. 69 (2006) 1633–1640.
[22] S.E. Laursen, J.K. Belknap, Intracerebroventricular injections in mice. Some
methodological reﬁnements, J. Pharmacol. Methods 16 (1986)
355–357.
[23] Q. Liang, X.P. Wang, T.S. Chen, Resveratrol protects rabbit articular
chondrocyte against sodium nitroprusside-induced apoptosis via scavenging
ROS, Apoptosis 19 (2014) 1354–1363.
[24] A. Lockwood, J. Patka, M. Rabinovich, K. Wyatt, P. Abraham, Sodium
nitroprusside-associated cyanide toxicity in adult patients—fact or ﬁction? A
critical review of the evidence and clinical relevance, Open Access J. Clin. Trials
2 (2010) 133–148.
[25] C. Loetchutinat, S. Kothan, S. Dechsupa, J. Meesungnoen, J.-P. Jay-Gerin, S.
Mankhetkorn, Spectroﬂuorometric determination of intracellular levels of
reactive oxygen species in drug-sensitive and drug-resistant cancer cells using
the 20 ,70-dichloroﬂuorescein diacetate assay, Radiat. Phys. Chem. 72 (2005)
323–331.
[26] O.V. Lushchak, V.I. Lushchak, Sodium nitroprusside induces mild oxidative
stress in Saccharomyces cerevisiae, Redox Rep. 13 (2008) 144–152.
[27] F.C. Meotti, E.C. Stangherlin, G. Zeni, C.W. Nogueira, J.B. Rocha, Protective role
of aryl and alkyl diselenides on lipid peroxidation, Environ. Res. 94 (2004)
276–282.
[28] K.M. Miranda, M.G. Espey, D.A. Wink, A rapid, simple spectrophotometric
method for simultaneous detection of nitrate and nitrite, Nitric Oxide 5 (2001)
62–71.
[29] H.P. Misra, I. Fridovich, The role of superoxide anion in the autoxidation of
epinephrine and a simple assay for superoxide dismutase, J. Biol. Chem. 247
(1972) 3170–3175.
[30] G. Naik, K. Priyadarsini, H. Mohan, Free radical scavenging reactions and
phytochemical analysis of triphala, an ayurvedic formulation, Curr. Sci. 90
(2006) 1100–1105.
[31] C.W. Nogueira, J.B.T. Rocha, Diphenyl diselenide a janus-faced molecule, J.
Braz. Chem. Soc. 21 (2010) 2055–2071.
[32] C.W. Nogueira, G. Zeni, J.B. Rocha, Organoselenium and organotellurium
compounds: toxicology and pharmacology, Chem. Rev. 104 (2004)
6255–6285.
[33] H. Ohkawa, N. Ohishi, K. Yagi, Assay for lipid peroxides in animal tissues by
thiobarbituric acid reaction, Anal. Biochem. 95 (1979) 351–358.
[34] R.E. Paciﬁci, K.J. Davies, Protein, lipid and DNA repair systems in oxidative
stress: the free-radical theory of aging revisited, Gerontology 37 (1991) 166–
180.
[35] B. Palmieri, V. Sblendorio, Oxidative stress tests: overview on reliability and
use. Part I, Eur. Rev. Med. Pharmacol. Sci. 11 (2007) 309–342.
[36] M. Prigol, C.A. Bruning, G. Zeni, C.W. Nogueira, Protective effect of
disubstituted diaryl diselenides on cerebral oxidative damage caused by
sodium nitroprusside, Biochem. Eng. J. 45 (2009) 94–99.
[37] G.O. Puntel, N.R. de Carvalho, P. Gubert, A.S. Palma, C.L. Dalla Corte, D.S. Avila,
M.E. Pereira, V.S. Carratu, L. Bresolin, J.B. da Rocha, F.A. Soares, Butane-2,3-
dionethiosemicarbazone: an oxime with antioxidant properties, Chem. Biol.
Interact. 177 (2009) 153–160.
[38] R. Re, N. Pellegrini, A. Proteggente, A. Pannala, M. Yang, C. Rice-Evans,
Antioxidant activity applying an improved ABTS radical cation decolorization
assay, Free Radic. Biol. Med. 26 (1999) 1231–1237.
[39] A.Z. Reznick, L. Packer, Oxidative damage to proteins: spectrophotometric
method for carbonyl assay, Methods Enzymol. 233 (1994) 357–363.
[40] J.A. Roehrs, R.P. Pistoia, D.F. Back, G. Zeni, Three-step one-pot synthesis of
imidazo[2,1-b]chalcogenazoles via intramolecular cyclization of N-, Adv.
Synth. Catal. 354 (2012) 1791–1796.
[41] S. Sassa, Delta-aminolevulinic acid dehydratase assay, Enzyme 28 (1982) 133–
145.
[42] J.B. Schulz, J. Lindenau, J. Seyfried, J. Dichgans, Glutathione, oxidative stress
and neurodegeneration, Eur. J. Biochem. 267 (2000) 4904–4911.
[43] R. Sharma, Y. Yang, A. Sharma, S. Awasthi, Y.C. Awasthi, Antioxidant role of
glutathione S-transferases: protection against oxidant toxicity and regulation
of stress-mediated apoptosis, Antioxid. Redox Signal. 6 (2004)
289–300.
[44] A.C. Souza, C. Luchese, J.S. Santos Neto, C.W. Nogueira, Antioxidant effect of a
novel class of telluroacetilene compounds: studies in vitro and in vivo, Life Sci.
84 (2009) 351–357.
[45] E. Stangherlin, C. Nogueira, Diphenyl ditelluride induces anxiogenic-like
behavior in rats by reducing glutamate uptake, Biol. Trace Elem. Res. 158
(2014) 392–398.
[46] D.A. Valerio, S.R. Georgetti, D.A. Magro, R. Casagrande, T.M. Cunha, F.T.
Vicentini, S.M. Vieira, M.J. Fonseca, S.H. Ferreira, F.Q. Cunha, W.A. Verri Jr.,
Quercetin reduces inﬂammatory pain: inhibition of oxidative stress and
cytokine production, J. Nat. Prod. 72 (2009) 1975–1979.
[47] L. Van Den Bosch, P. Van Damme, E. Bogaert, W. Robberecht, The role of
excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis, Biochim.
Biophys. Acta 1762 (2006) 1068–1082.
24 P.M. Chagas et al. / Chemico-Biological Interactions 233 (2015) 14–24[48] W.B. Veldhuis, M. van der Stelt, F. Delmas, B. Gillet, G.A. Veldink, J.F.
Vliegenthart, K. Nicolay, P.R. Bar, In vivo excitotoxicity induced by ouabain, a
Na+/K+-ATPase inhibitor, J. Cereb. Blood Flow Metab. 23 (2003) 62–74.
[49] M.P. Washburn, W.W. Wells, Identiﬁcation of the dehydroascorbic acid
reductase and thioltransferase (Glutaredoxin) activities of bovineerythrocyte glutathione peroxidase, Biochem. Biophys. Res. Commun. 257
(1999) 567–571.
[50] W.W. Wells, D.P. Xu, M.P. Washburn, Glutathione: dehydroascorbate
oxidoreductases, Methods Enzymol. 252 (1995) 30–38.
[51] A. Wendel, Glutathione peroxidase, Methods Enzymol. 77 (1981) 325–333.
